3rd Edition of International Cancer & Immuno-Oncology Conference

Held from March 15-17, 2027 in Singapore as a hybrid event (in-person at Village Hotel Changi), the 3rd Edition of International Cancer & Immuno-Oncology Conference (CIOC 2027) is structured as a CPD-accredited meeting for the international cancer research and clinical oncology community. The three-day programme delivers subspecialty updates, practical demonstrations, and case-based discussions that help researchers, clinicians, and practitioners maintain a strong evidence base across oncology. The Cancer Treatment Conference 2027 covers immuno-oncology, cell and gene therapy in oncology, antibody-drug conjugates (ADCs), precision oncology and biomarkers, liquid biopsy and minimal residual disease (MRD), early detection and screening, AI and imaging in oncology, trials design and innovation, real-world data and outcomes, peri- and neoadjuvant strategies, treatment resistance and sequencing, supportive care and survivorship, oncology nursing practice, and health economics, access and policy. CPD certificates of attendance are issued to all registered delegates and presenters; abstract acceptance for oral or poster presentation provides additional academic recognition. Among the Oncology Summit 2027 calendar for the year, this meeting offers tiered registration - abstract review for speakers and early-bird registration for delegates and listeners. Reach us at: E-mail: cancer-research@magnusconference.com Phone: +1 (702) 988-2320 WhatsApp: +1 (640) 666-9566 Website: https://cancer-conferences.magnusgroup.org/ Cancer Conference 2027 | International Cancer Conference 2027 | Cancer Research Conference 2027 | Cancer Summit 2027 | Cancer Conference Singapore | Cancer Symposium 2027 | Oncology Conference 2027 | Oncology Summit 2027 | International Oncology Conference | Clinical Oncology Conference 2027 | Cancer Treatment Conference 2027 | Upcoming Cancer Conferences 2027